BNGO / Bionano Is Not the Genomics Stock To Bet On

One of the New York Yankees' most well-known players', Yogi Berra, famous for his strange, yet funny statements, used to say, “This is deja vu all o more_horizontal

Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 more_horizontal

Due to a combination of worries about high-interest rates, China's decision to prevent some government employees from using Apple's (NASDAQ: AAPL ) iP more_horizontal

Sometimes I really question why we're still talking about meme stocks. When will investors learn that the unpredictable nature of meme stocks nearly a more_horizontal

One of its top executives is departing. He will be replaced effective Sept. more_horizontal

Short squeezes affect heavily shorted stocks when many sellers are forced to buy back the shares they shorted. That dynamic, in turn, causes the stock more_horizontal

Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $0.90. This compares more_horizontal

Bionano Genomics, Inc. (NASDAQ:BNGO ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants David Holmes - IR Erik Holmlin - more_horizontal